Health
Clinical, regulatory, and corporate news from the healthcare sector.
Unicycive Resubmits Kidney Drug NDA and Adds Meredith Manning to Board
Unicycive’s new drug application for oxylanthanum carbonate now includes a year of stability data from a newly FDA-inspected vendor, with an FDA decision expected in six months.
- Health
Jasper Therapeutics CFO Herb Cross Resigns; CEO Jeet Mahal Takes Interim Role
Herb Cross will step down as CFO of Jasper Therapeutics on October 9, with CEO Jeet Mahal named interim finance chief, marking a significant change in the company’s leadership.
- Health
Stoke Therapeutics Names Alexander Cumbo to Board as Edward Kaye Exits
Edward Kaye resigned from Stoke Therapeutics’ board on September 23, 2026, with Alexander Cumbo appointed as his independent replacement, signaling a key leadership transition for the company.
- Health
Zymeworks Buys Theravance Biopharma, Issues Contingent Value Rights
Zymeworks has completed its acquisition of Theravance Biopharma and issued contingent value rights to eligible former Theravance holders, expanding its healthcare portfolio.
- Health
MeiraGTx Adds Healthcare Veteran Alan Sebulsky to Board
Alan M. Sebulsky, with over 40 years of healthcare experience, joins MeiraGTx’s board and Science and Technology Committee, effective September 2026, bringing investment expertise to the company.
- Health
Valion Bio Reports Officer Change and New Disclosure to SEC
Valion Bio filed an 8-K noting an officer change and Regulation FD update, as its share price dropped 60.5% over the past month, raising governance and transparency questions.
- Health
Boston Scientific Reports Leadership Change in Recent SEC Filing
Boston Scientific disclosed a change involving its directors or officers in its sixth SEC filing in 90 days, but did not specify who or why, leaving investors uncertain about the impact.
- Health
Halozyme Raises $1.5 Billion, Retires Older Debt with New Notes
Halozyme Therapeutics raised $1.5 billion through convertible notes, using the funds to repurchase $371.7 million of 2027 and 2028 debt and fund capped call transactions.
- Health
Calidi Biotherapeutics Raises $1.2 Million in Direct Stock Sale
Calidi Biotherapeutics sold over 1 million shares at $1.17 each to accredited investors, raising $1.2 million in new funding for working capital and corporate needs.
- Health
Tessera Defense Boosts MEA Testing Stake to 15%, Changes Payment Terms
Tessera Defense & Homeland Security is increasing its planned investment in MEA Testing Systems from 10% to 15% and revising payment terms to include more shares and a loan advance.
- Health
GE HealthCare Names Pascal Desroches to Board Starting 2027
Pascal Desroches will join GE HealthCare's board and two key committees as a non-employee director on January 4, 2027, following a recent board appointment.
- Health
Cypherpunk Names Amanda Fabiano to Board with 250,000 RSUs
Amanda Fabiano joins Cypherpunk Technologies’ board immediately and receives 250,000 restricted stock units vesting over three years, highlighting the company’s latest leadership and compensation move.
- Health
Scynexis Reports Director or Officer Change in New SEC Filing
Scynexis disclosed a change involving a director or officer in its fifth SEC filing in 90 days, but did not name the person or explain the move.
- Health
GT Biopharma Ups Preferred Stock Offering to $8.6 Million
GT Biopharma expanded its private placement, raising the stated value of its Series M preferred stock to $8.6 million and adding Greenshoe Rights for further purchases.
- Health
Insulet Cuts Loan Costs and Boosts Credit Line by $250 Million
Insulet refinanced $475 million in term loans at a 0.25% lower interest margin and increased its revolving credit facility to $750 million, improving financial flexibility.
- Health
CVRx Names John Landry as New CFO After Q3 Filing
John Landry, previously at Nyxoah, will take over as CVRx’s chief financial officer with a $500,000 base salary and equity awards after the third quarter report.
- Health
US Physical Therapy Reports Officer or Director Change in SEC Filing
US Physical Therapy disclosed a change involving an officer or director in its September 21 SEC filing, but did not specify the individual or role, leaving details unclear for investors.
- Health
InspireMD Reveals New Agreement and Equity Sale in SEC Filing
InspireMD disclosed a new material agreement and an unregistered equity sale in its latest 8-K, but provided no updates on clinical trials or product pipeline progress.
- Health
Avantor Hires Todd Garner as CFO with $700,000 Salary
Avantor named Todd Garner, former CONMED CFO, as its new finance chief with a $700,000 base salary and $1.5 million equity grant, signaling a leadership shift.
- Health
Adial Drops Penalty Terms from Investor Deals to Address Nasdaq Risks
Adial Pharmaceuticals removed penalty provisions from PIPE and noteholder agreements on September 16, aiming to resolve Nasdaq equity compliance issues caused by warrant accounting rules.
- Health
Tenon Medical Raises $2.87 Million by Swapping Warrants
Tenon Medical will issue new five-year Series B warrants for 858,269 shares at $5.02 each, raising $2.87 million for working capital and general purposes.
- Health
Gossamer Bio Adds Greg Ciongoli to Board and Audit Committee
Greg Ciongoli, founder of Adiumentum Capital and former Baupost partner, joins Gossamer Bio’s board as an independent director, marking the company’s sixth SEC filing in 90 days.
- Health
Ernexa Therapeutics Adds Dr. Robert J. Spiegel to Board
Dr. Robert J. Spiegel joins Ernexa's board effective September 14, 2026, with compensation under the company's director plan, signaling board refresh but no pipeline change.
- Health
CapsoVision Raises $18 Million from Major Shareholders at 5% Discount
CapsoVision secured $18 million in a direct stock sale to two 10% owners at a 5% discount, bolstering its cash for general operations and R&D.
